KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $27.5 million.

  • Evolent Health's Change in Accured Expenses rose 955894.74% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.2 million, marking a year-over-year increase of 17759.91%. This contributed to the annual value of -$24.2 million for FY2024, which is 20230.41% down from last year.
  • According to the latest figures from Q3 2025, Evolent Health's Change in Accured Expenses is $27.5 million, which was up 955894.74% from $13.0 million recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Change in Accured Expenses ranged from a high of $48.2 million in Q3 2023 and a low of -$32.4 million during Q1 2022
  • In the last 5 years, Evolent Health's Change in Accured Expenses had a median value of $582000.0 in 2024 and averaged -$217736.8.
  • As far as peak fluctuations go, Evolent Health's Change in Accured Expenses plummeted by 33738.74% in 2023, and later soared by 955894.74% in 2025.
  • Quarter analysis of 5 years shows Evolent Health's Change in Accured Expenses stood at $17.4 million in 2021, then tumbled by 105.09% to -$888000.0 in 2022, then crashed by 337.39% to -$3.9 million in 2023, then surged by 114.98% to $582000.0 in 2024, then surged by 4629.9% to $27.5 million in 2025.
  • Its last three reported values are $27.5 million in Q3 2025, $13.0 million for Q2 2025, and -$18.9 million during Q1 2025.